Reporters.io
PT Staff
Pharmacy Times
Profile
Contacts
Recent Articles on Subject
1
PT Staff
Pharmacy Times
#pharmacy news, insights. CE provider.
Cranbury, New Jersey
pharmacy
healthcare
journalism
October 2024 Product News
- 2 months ago
Pharmacist Spotlight: Anjeza Fero, PharmD, RPh
- 3 months ago
September 2024 Pharmacy Policy
- 3 months ago
Product News: August 2024
- 4 months ago
Pharmacy Policy, August 2024
- 4 months ago
Pharmacist Spotlight: Cassandra Esperant, PharmD, AAHIVP
- 5 months ago
Condition Watch, June 2024
- 6 months ago
June 2024 Products Column
- 6 months ago
Pharmacist Spotlight: Amina Abubakar, PharmD, AAHIVP
- 6 months ago
Pharmacy Policy Updates, March 2024
- 9 months ago
Pharmacist Spotlight: Natalie Young, PharmD, BCSCP
- 9 months ago
Condition Watch: Dry Eye Relief
- 9 months ago
Condition Watch: Migraine
- 10 months ago
Generic Product News: December 2023
- about 1 year ago
OTC Product News: December 2023
- about 1 year ago
Pharmacist Spotlight: Jake Galdo, PharmD, MBA
- about 1 year ago
Pharmacist Spotlight: Joanna Lewis, PharmD, MBA
- about 1 year ago
Condition State Management: Substance Abuse
- about 1 year ago
Generic Product News - November 2023
- about 1 year ago
Rx Product News - November 2023
- about 1 year ago
OTC Product News: November 2023
- about 1 year ago
FDA Approves Faricimab for Macular Edema Following Retinal Vein Occlusion
- about 1 year ago
FDA Approves Mirikizumab for Moderately to Severely Active Ulcerative Colitis
- about 1 year ago
Subcutaneous Lecanemab Found Equally Effective as IV Version in Alzheimer Disease Treatment
- about 1 year ago
CDC Issues Alert to Address Shortage of RSV Treatment Nirsevimab
- about 1 year ago
Phase 3 Trial Begins for Combination Influenza and COVID-19 Vaccine
- about 1 year ago
Condition State Management: Stroke Watch
- about 1 year ago
FDA Approves Pentavalent Vaccine for Most Common Serogroups That Cause Meningococcal Disease
- about 1 year ago
FDA Approves Pembrolizumab Resectable Non–Small Cell Lung Cancer
- about 1 year ago
FDA Approves Nivolumab for Completely Resected Stage IIB or Stage IIC Melanoma in Adult, Pediatric Patients
- about 1 year ago
FDA Approves Encorafenib Plus Binimetinib Combination for Non-Small Cell Lung Cancer
- about 1 year ago
Study Highlights Impact of Preventive Strategies for RSV Hospitalizations in Pediatric Patients
- about 1 year ago
FDA Issues Emergency Use Authorization to Novavax’s COVID-19 Vaccine 2023-24 Formula
- about 1 year ago
Menopause Condition Watch
- over 1 year ago
FDA Approves Momelotinib to Treat Myelofibrosis Patients With Anemia
- over 1 year ago